Dementia has a reversible cause in some cases, and these should be dia
gnosed without over-investigating the many patients with irreversible
disease. We prospectively studied the prevalence of reversible dementi
a in a memory clinic, determined the added value of investigations com
pared with clinical examination and assessed the outcome of treatment
of potentially reversible causes by measuring (1) cognition, (2) disab
ility in daily functioning, (3) behavioural changes and (4) caregiver
burden. Two hundred patients aged 65 years and over were examined, usi
ng the CAMDEX-N. If they were demented, the probable cause was diagnos
ed clinically and confirmed or excluded by a standard set of investiga
tions, which were done in all patients. Of the patients, 170 (mean age
79.2 years) were demented; 31 were treated for potentially reversible
causes. At follow-up after 6 months, no patients showed complete reve
rsal of dementia. Five patients improved on clinical impression, but o
nly one on clinicial measurement. Thirty patients were cognitively imp
aired, but not demented; seven were treated. Judged clinically, three
patients improved, but on assessment only one did so; she recovered co
mpletely. Blood tests often produced diagnostic results that were not
expected clinically, but electroencephalography and computed tomograph
y of the brain did not. None of the investigations had an effect on ou
tcome of dementia after treatment. We conclude that in elderly patient
s referred to a memory clinic, the prevalence of reversible dementia i
s of the order of 1%, if outcome after treatment is assessed by a stan
dardized measurement. We recommend blood tests in all patients, to det
ect not only metabolic causes of dementia but also co-morbidity possib
ly worsening the dementia. Other investigations can be performed on cl
inical indication. Clinical evaluation remains the mainstay of diagnos
is in dementia.